3 months of anticoagulation therapy might be too long for young patients with provoked VTE Three months of anticoagulation therapy is the go-to option when treating these younger patients—but it could be time for a change.Read more about 3 months of anticoagulation therapy might be too long for young patients with provoked VTE
Rural heart attack patients started taking longer to seek care when the pandemic began This trend was even seen in areas where COVID-19 rates were relatively low, researchers found.Read more about Rural heart attack patients started taking longer to seek care when the pandemic began
TPVR with the Melody valve associated with strong 10-year outcomes, helping patients avoid surgery All patients originally presented with a dysfunctional RVOT conduit or stented bioprosthetic pulmonary valve.Read more about TPVR with the Melody valve associated with strong 10-year outcomes, helping patients avoid surgery
Cardiac resynchronization therapy boosts care for older HFrEF patients All patients included in the analysis faced a high risk of complications, researchers noted. Read more about Cardiac resynchronization therapy boosts care for older HFrEF patients
Even mild COVID-19 cases can result in lingering heart issues The study included more than 400 patients with a history of mild or moderate COVID-19. Read more about Even mild COVID-19 cases can result in lingering heart issues
High levels of ‘good’ cholesterol may be bad for men This trend, however, did not carry over to women with high HDL-C levels. Read more about High levels of ‘good’ cholesterol may be bad for men
Meet the RNA molecule that guards against vascular disease Researchers hope their work can help guide future treatments for atherosclerosis and other harmful diseases. Read more about Meet the RNA molecule that guards against vascular disease
Diabetes, hypertension more common among breast cancer survivors Women who received left-sided radiation or endocrine therapy appear to be impacted the most by this trend. Read more about Diabetes, hypertension more common among breast cancer survivors
FDA announces a new recall for extended-release metformin due to contamination The FDA first announced the detection of high levels of NDMA, a contaminant associated with cancer, in extended-release metformin products back in May 2020. Read more about FDA announces a new recall for extended-release metformin due to contamination
RAAS inhibitors help limit adverse outcomes among CAD patients The study included data from more than 165,000 patients with coronary artery disease (CAD).Read more about RAAS inhibitors help limit adverse outcomes among CAD patients
